Physitrack Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	13.62	13.52	13.87	14.75	12.51	7.81
Revenue	13.62	13.52	13.87	14.75	12.51	7.81
Revenue Growth (YoY)	2.20%	-2.50%	-5.97%	17.87%	60.10%	155.86%
Cost of Revenue	4.82	4.68	5.62	11.31	9.1	0
Gross Profit	8.81	8.84	8.25	3.44	3.42	7.81
Selling, General & Admin	-	-	-	-	-	5.36
Amortization of Goodwill & Intangibles	4.17	4.17	4.38	3.58	2.4	1.42
Operating Expenses	7.89	8.34	8.61	3.58	2.4	6.78
Operating Income	0.92	0.51	-0.37	-0.14	1.01	1.03
Interest Expense	-0.42	-0.52	-0.5	-0.38	-0.09	-0.07
Interest & Investment Income	0.02	0.02	0.02	0.02	0.03	0.01
Other Non Operating Income (Expenses)	0	-	-	-	-	-
EBT Excluding Unusual Items	0.52	0.01	-0.85	-0.49	0.95	0.96
Merger & Restructuring Charges	-0.48	-0.48	-1.39	-0.8	-1.41	-0.5
Impairment of Goodwill	-5.55	-5.55	1.74	-3.29	-	-
Legal Settlements	-0.28	-0.28	-0.11	-	-	-
Other Unusual Items	-0.33	-0.33	-	7.25	0.5	-1.11
Pretax Income	-6.12	-6.63	-0.61	2.66	0.05	-0.64
Income Tax Expense	0.06	-0.02	-0.44	-0.16	-0.04	0.17
Earnings From Continuing Operations	-6.18	-6.61	-0.16	2.82	0.09	-0.82
Earnings From Discontinued Operations	-2.22	-2.1	-6.29	-	-	-
Net Income	-8.4	-8.71	-6.45	2.82	0.09	-0.82
Net Income to Common	-8.4	-8.71	-6.45	2.82	0.09	-0.82
Net Income Growth	-	-	-	2955.19%	-	-
Shares Outstanding (Basic)	-	16	16	16	16	14
Shares Outstanding (Diluted)	-	16	16	16	16	14
Shares Change (YoY)	-	-	-	-	18.78%	32.15%
EPS (Basic)	-	-0.54	-0.40	0.17	0.01	-0.06
EPS (Diluted)	-	-0.54	-0.40	0.17	0.01	-0.06
EPS Growth	-	-	-	2894.52%	-	-
Free Cash Flow	3.93	4.15	3.08	2.62	1.38	0.65
Free Cash Flow Per Share	-	0.26	0.19	0.16	0.09	0.05
Gross Margin	64.64%	65.42%	59.47%	23.30%	27.30%	99.96%
Operating Margin	6.72%	3.76%	-2.64%	-0.97%	8.09%	13.19%
Profit Margin	-61.64%	-64.42%	-46.55%	19.13%	0.74%	-10.43%
Free Cash Flow Margin	28.84%	30.70%	22.23%	17.79%	11.01%	8.37%
EBITDA	4.77	4.56	3.75	3.38	1.34	1.07
EBITDA Margin	35.02%	33.73%	27.03%	22.93%	10.71%	13.63%
D&A For EBITDA	3.85	4.05	4.11	3.52	0.33	0.03
EBIT	0.92	0.51	-0.37	-0.14	1.01	1.03
EBIT Margin	6.72%	3.76%	-2.64%	-0.97%	8.09%	13.19%

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.